ITGAX and neoplasm: The characterization of the tumour immune microenvironment of KEAP1-mutant tumours in a K1P mouse model showed impaired expansion of CD11c+ immune cells, further emphasizing the immunosuppressive effects of KEAP1 mutations [71].